However, we currently could not clarify ADV infection or HMGB1 treatment promotes dedifferentiation of differentiated glioma cells, or they promote the proliferation of rare GSCs in the stocks of patient-derived primary glioma cells. The gene discussed is HMGB1; the disease is glioma.